Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05568134 · ClinicalTrials.gov registry record
Alternate Measures of Glucose During OGTT Testing for CFRD
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 14
- Enrollment target
NCT05568134 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 14 participants.
The verdict
NCT05568134 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
Although early detection and treatment of cystic fibrosis-related diabetes (CFRD) can lead to significant clinical improvements and prolong life, rates of screening are poor likely due to the burdensome nature of oral glucose tolerance testing (OGTT). The investigators propose to assess the feasibility and accuracy of two screening tools, continuous glucose monitoring (CGM) and a home OGTT kit (GTT@home). If this pilot study reveals acceptable accuracy of either device, this study will allow for future studies exploring home-based OGTT screening.
Interventions
- DIAGNOSTIC_TEST Oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2024-12-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05568134
The ClinicalTrials.gov registry entry for NCT05568134 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral glucose tolerance test is the first listed.
NCT05568134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05568134 about?
NCT05568134 is a clinical study titled "Alternate Measures of Glucose During OGTT Testing for CFRD". Although early detection and treatment of cystic fibrosis-related diabetes (CFRD) can lead to significant clinical improvements and prolong life, rates of screening are poor likely due to the burdensome nature of oral glucose tolerance testing (OGTT). The investigators propose to assess the feasibil...
What is the current status of trial NCT05568134?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2023-07-17. Estimated completion is 2024-12-13.
What interventions are being tested in trial NCT05568134?
The interventions under investigation include: Oral glucose tolerance test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05568134?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.